Blood pressure-lowering effects of biofeedback treatment in hypertension: A meta-analysis of randomized controlled trials

Mutsuhiro Nakao, Eiji Yano, Shinobu Nomura, Tomifusa Kuboki

    Research output: Contribution to journalArticle

    50 Citations (Scopus)

    Abstract

    To examine the blood pressure-lowering effects of biofeedback treatment in patients with essential hypertension, a meta-analysis was conducted on studies published between 1966 and 2001. A total of 22 randomized controlled studies with 905 essential hypertensive patients were selected for review. Compared with clinical visits or self-monitoring of blood pressure (non-intervention controls), biofeedback intervention resulted in systolic and diastolic blood pressure reductions that were greater by 7.3 mmHg (for systole; 95% confidence interval: 2.6 to 12.0) and 5.8 mmHg (for diastole; 95% confidence interval: 2.9 to 8.6). Compared with sham or non-specific behavioral intervention controls, the net reductions in systolic and diastolic blood pressures by biofeedback intervention were 3.9 (95% confidence interval: -0.3 to 8.2) and 3.5 (-0.1 to 7.0) mmHg, respectively. The results of multiple regression analysis also indicated that biofeedback intervention decreased systolic and diastolic blood pressures more than non-intervention controls (p<0.001), but not more than sham or non-specific behavioral intervention controls (p>0.05), when controlling for the effects of initial blood pressures. When biofeedback intervention types were classified into two types, simple biofeedback and relaxation-assisted biofeedback, only the relaxation-assisted biofeedback significantly decreased both systolic and diastolic blood pressures (p<0.05) compared with those in sham or non-specific behavioral intervention controls. The results suggested that biofeedback was more effective in reducing blood pressure in patients with essential hypertension than no intervention. However, the treatment was only found to be superior to sham or non-specific behavioral intervention when combined with other relaxation techniques. Further studies will be needed to determine whether biofeedback itself has an antihypertensive effect beyond the general relaxation response.

    Original languageEnglish
    Pages (from-to)37-46
    Number of pages10
    JournalHypertension Research
    Volume26
    Issue number1
    Publication statusPublished - 2003 Jan

    Fingerprint

    Meta-Analysis
    Randomized Controlled Trials
    Blood Pressure
    Hypertension
    Therapeutics
    Confidence Intervals
    Relaxation Therapy
    Biofeedback (Psychology)
    Ambulatory Blood Pressure Monitoring
    Diastole
    Systole
    Antihypertensive Agents
    Regression Analysis

    Keywords

    • Biofeedback
    • Blood pressure
    • Hypertension
    • Meta-analysis
    • Randomized controlled trial

    ASJC Scopus subject areas

    • Internal Medicine

    Cite this

    Blood pressure-lowering effects of biofeedback treatment in hypertension : A meta-analysis of randomized controlled trials. / Nakao, Mutsuhiro; Yano, Eiji; Nomura, Shinobu; Kuboki, Tomifusa.

    In: Hypertension Research, Vol. 26, No. 1, 01.2003, p. 37-46.

    Research output: Contribution to journalArticle

    Nakao, Mutsuhiro ; Yano, Eiji ; Nomura, Shinobu ; Kuboki, Tomifusa. / Blood pressure-lowering effects of biofeedback treatment in hypertension : A meta-analysis of randomized controlled trials. In: Hypertension Research. 2003 ; Vol. 26, No. 1. pp. 37-46.
    @article{46f5e6bdd2354d96bed49b07a3171d64,
    title = "Blood pressure-lowering effects of biofeedback treatment in hypertension: A meta-analysis of randomized controlled trials",
    abstract = "To examine the blood pressure-lowering effects of biofeedback treatment in patients with essential hypertension, a meta-analysis was conducted on studies published between 1966 and 2001. A total of 22 randomized controlled studies with 905 essential hypertensive patients were selected for review. Compared with clinical visits or self-monitoring of blood pressure (non-intervention controls), biofeedback intervention resulted in systolic and diastolic blood pressure reductions that were greater by 7.3 mmHg (for systole; 95{\%} confidence interval: 2.6 to 12.0) and 5.8 mmHg (for diastole; 95{\%} confidence interval: 2.9 to 8.6). Compared with sham or non-specific behavioral intervention controls, the net reductions in systolic and diastolic blood pressures by biofeedback intervention were 3.9 (95{\%} confidence interval: -0.3 to 8.2) and 3.5 (-0.1 to 7.0) mmHg, respectively. The results of multiple regression analysis also indicated that biofeedback intervention decreased systolic and diastolic blood pressures more than non-intervention controls (p<0.001), but not more than sham or non-specific behavioral intervention controls (p>0.05), when controlling for the effects of initial blood pressures. When biofeedback intervention types were classified into two types, simple biofeedback and relaxation-assisted biofeedback, only the relaxation-assisted biofeedback significantly decreased both systolic and diastolic blood pressures (p<0.05) compared with those in sham or non-specific behavioral intervention controls. The results suggested that biofeedback was more effective in reducing blood pressure in patients with essential hypertension than no intervention. However, the treatment was only found to be superior to sham or non-specific behavioral intervention when combined with other relaxation techniques. Further studies will be needed to determine whether biofeedback itself has an antihypertensive effect beyond the general relaxation response.",
    keywords = "Biofeedback, Blood pressure, Hypertension, Meta-analysis, Randomized controlled trial",
    author = "Mutsuhiro Nakao and Eiji Yano and Shinobu Nomura and Tomifusa Kuboki",
    year = "2003",
    month = "1",
    language = "English",
    volume = "26",
    pages = "37--46",
    journal = "Hypertension Research",
    issn = "0916-9636",
    publisher = "Nature Publishing Group",
    number = "1",

    }

    TY - JOUR

    T1 - Blood pressure-lowering effects of biofeedback treatment in hypertension

    T2 - A meta-analysis of randomized controlled trials

    AU - Nakao, Mutsuhiro

    AU - Yano, Eiji

    AU - Nomura, Shinobu

    AU - Kuboki, Tomifusa

    PY - 2003/1

    Y1 - 2003/1

    N2 - To examine the blood pressure-lowering effects of biofeedback treatment in patients with essential hypertension, a meta-analysis was conducted on studies published between 1966 and 2001. A total of 22 randomized controlled studies with 905 essential hypertensive patients were selected for review. Compared with clinical visits or self-monitoring of blood pressure (non-intervention controls), biofeedback intervention resulted in systolic and diastolic blood pressure reductions that were greater by 7.3 mmHg (for systole; 95% confidence interval: 2.6 to 12.0) and 5.8 mmHg (for diastole; 95% confidence interval: 2.9 to 8.6). Compared with sham or non-specific behavioral intervention controls, the net reductions in systolic and diastolic blood pressures by biofeedback intervention were 3.9 (95% confidence interval: -0.3 to 8.2) and 3.5 (-0.1 to 7.0) mmHg, respectively. The results of multiple regression analysis also indicated that biofeedback intervention decreased systolic and diastolic blood pressures more than non-intervention controls (p<0.001), but not more than sham or non-specific behavioral intervention controls (p>0.05), when controlling for the effects of initial blood pressures. When biofeedback intervention types were classified into two types, simple biofeedback and relaxation-assisted biofeedback, only the relaxation-assisted biofeedback significantly decreased both systolic and diastolic blood pressures (p<0.05) compared with those in sham or non-specific behavioral intervention controls. The results suggested that biofeedback was more effective in reducing blood pressure in patients with essential hypertension than no intervention. However, the treatment was only found to be superior to sham or non-specific behavioral intervention when combined with other relaxation techniques. Further studies will be needed to determine whether biofeedback itself has an antihypertensive effect beyond the general relaxation response.

    AB - To examine the blood pressure-lowering effects of biofeedback treatment in patients with essential hypertension, a meta-analysis was conducted on studies published between 1966 and 2001. A total of 22 randomized controlled studies with 905 essential hypertensive patients were selected for review. Compared with clinical visits or self-monitoring of blood pressure (non-intervention controls), biofeedback intervention resulted in systolic and diastolic blood pressure reductions that were greater by 7.3 mmHg (for systole; 95% confidence interval: 2.6 to 12.0) and 5.8 mmHg (for diastole; 95% confidence interval: 2.9 to 8.6). Compared with sham or non-specific behavioral intervention controls, the net reductions in systolic and diastolic blood pressures by biofeedback intervention were 3.9 (95% confidence interval: -0.3 to 8.2) and 3.5 (-0.1 to 7.0) mmHg, respectively. The results of multiple regression analysis also indicated that biofeedback intervention decreased systolic and diastolic blood pressures more than non-intervention controls (p<0.001), but not more than sham or non-specific behavioral intervention controls (p>0.05), when controlling for the effects of initial blood pressures. When biofeedback intervention types were classified into two types, simple biofeedback and relaxation-assisted biofeedback, only the relaxation-assisted biofeedback significantly decreased both systolic and diastolic blood pressures (p<0.05) compared with those in sham or non-specific behavioral intervention controls. The results suggested that biofeedback was more effective in reducing blood pressure in patients with essential hypertension than no intervention. However, the treatment was only found to be superior to sham or non-specific behavioral intervention when combined with other relaxation techniques. Further studies will be needed to determine whether biofeedback itself has an antihypertensive effect beyond the general relaxation response.

    KW - Biofeedback

    KW - Blood pressure

    KW - Hypertension

    KW - Meta-analysis

    KW - Randomized controlled trial

    UR - http://www.scopus.com/inward/record.url?scp=0037272849&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0037272849&partnerID=8YFLogxK

    M3 - Article

    C2 - 12661911

    AN - SCOPUS:0037272849

    VL - 26

    SP - 37

    EP - 46

    JO - Hypertension Research

    JF - Hypertension Research

    SN - 0916-9636

    IS - 1

    ER -